22 May 2024

London-based LabGenius, which uses ML to find and design antibody therapies to treat cancer, raised a £35M Series B led by Merck's VC arm, M Ventures (Mimi Billing/Sifted)

Podcast cover

Techmeme

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

London-based LabGenius, which uses ML to find and design antibody therapies to treat cancer, raised a £35M Series B led by Merck's VC arm, M Ventures (Mimi Billing/Sifted)